Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2016

Open Access 01-12-2016 | Research

Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog

Authors: David Otiashvili, Alisher Latypov, Irma Kirtadze, Umedjon Ibragimov, William Zule

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2016

Login to get access

Abstract

Background

Sharing injection equipment remains an important rout of transmission of HIV and HCV infections in the region of Eastern Europe and Central Asia. Tajikistan is one of the most affected countries with high rates of injection drug use and related epidemics.The aim of this qualitative study was to describe drug use practices and related behaviors in two Tajik cities – Kulob and Khorog.

Methods

Twelve focus group discussions (6 per city) with 100 people who inject drugs recruited through needle and syringe program (NSP) outreach in May 2014. Topics covered included specific drugs injected, drug prices and purity, access to sterile equipment, safe injection practices and types of syringes and needles used. Qualitative thematic analysis was performed using NVivo 10 software.

Results

All participants were male and ranged in age from 20 to 78 years. Thematic analysis showed that cheap Afghan heroin, often adulterated by dealers with other admixtures, was the only drug injected. Drug injectors often added Dimedrol (Diphenhydramine) to increase the potency of “low quality” heroin. NSPs were a major source of sterile equipment. Very few participants report direct sharing of needles and syringes. Conversely, many participants reported preparing drugs jointly and sharing injection paraphernalia. Using drugs in an outdoor setting and experiencing withdrawal were major contributors to sharing equipment, using non-sterile water, not boiling and not filtering the drug solution.

Conclusion

Qualitative research can provide insights into risk behaviors that may be missed in quantitative studies. These finding have important implications for planning risk reduction interventions in Tajikistan. Prevention should specifically focus on indirect sharing practices.
Literature
1.
go back to reference Ancker S, Rechel B. Policy responses to HIV/AIDS in Central Asia. Glob Public Health. 2015;10(7):817–33.CrossRefPubMed Ancker S, Rechel B. Policy responses to HIV/AIDS in Central Asia. Glob Public Health. 2015;10(7):817–33.CrossRefPubMed
2.
go back to reference DeHovitz J, Uuskula A, El-Bassel N. The HIV epidemic in Eastern Europe and Central Asia. Curr HIV/AIDS Rep. 2014;11(2):168–76.CrossRefPubMed DeHovitz J, Uuskula A, El-Bassel N. The HIV epidemic in Eastern Europe and Central Asia. Curr HIV/AIDS Rep. 2014;11(2):168–76.CrossRefPubMed
3.
go back to reference Latypov A, Otiashvili D, Zule W. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan. Int J Drug Policy. 2014;25(6):1204–14.CrossRefPubMedPubMedCentral Latypov A, Otiashvili D, Zule W. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan. Int J Drug Policy. 2014;25(6):1204–14.CrossRefPubMedPubMedCentral
4.
go back to reference Ministry of Health of Republic of Tajikistan. UNAIDS country progress report. Dushanbe: Ministry of Health of Republic of Tajikistan; 2015. Ministry of Health of Republic of Tajikistan. UNAIDS country progress report. Dushanbe: Ministry of Health of Republic of Tajikistan; 2015.
5.
go back to reference Ministry of Health of Republic of Tajikistan. Report on the results of bio-behavioral surveliance survey among people who inject drugs in Republic of Tajikistan in 2014. 2015. Ministry of Health of Republic of Tajikistan. Report on the results of bio-behavioral surveliance survey among people who inject drugs in Republic of Tajikistan in 2014. 2015.
6.
go back to reference Drug Control Agency under the President of Republic of Tajikistan. Drug situation in the Republic of Tajikistan in 2014. 2015. Drug Control Agency under the President of Republic of Tajikistan. Drug situation in the Republic of Tajikistan in 2014. 2015.
8.
go back to reference Tukeyev M, Ganina L, Yelizarieva A, Petrenko I, Balabayev T, Kudusova E, et al. 2006–2010 Kazakhstan National AIDS Programme Progress Report. Astana: Ministry of Health of the Republic of Kazakhstan. 2011. Tukeyev M, Ganina L, Yelizarieva A, Petrenko I, Balabayev T, Kudusova E, et al. 2006–2010 Kazakhstan National AIDS Programme Progress Report. Astana: Ministry of Health of the Republic of Kazakhstan. 2011.
9.
go back to reference Ministry of Health of Republic of Tajikistan, UNDP. Modelling an optimised investment approach for Tajikistan. Dushanbe: UNDP; 2014. Ministry of Health of Republic of Tajikistan, UNDP. Modelling an optimised investment approach for Tajikistan. Dushanbe: UNDP; 2014.
10.
go back to reference MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34–52.CrossRefPubMed MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34–52.CrossRefPubMed
11.
go back to reference Palmateer N, Hutchinson S, McAllister G, Munro A, Cameron S, Goldberg D, et al. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat. 2014;21(1):25–32.CrossRefPubMed Palmateer N, Hutchinson S, McAllister G, Munro A, Cameron S, Goldberg D, et al. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat. 2014;21(1):25–32.CrossRefPubMed
12.
go back to reference Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005;9(1):27–39.CrossRefPubMed Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005;9(1):27–39.CrossRefPubMed
13.
go back to reference Rhodes T, Mikhailova L, Sarang A, Lowndes CM, Rylkov A, Khutorskoy M. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003;57(1):39–54. Rhodes T, Mikhailova L, Sarang A, Lowndes CM, Rylkov A, Khutorskoy M. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003;57(1):39–54.
14.
go back to reference Wilkins L, Bissell P, Meier PS. Risky injecting practices associated with snowballing: a qualitative study. Drug Alcohol Rev. 2010;29(3):256–62.CrossRefPubMed Wilkins L, Bissell P, Meier PS. Risky injecting practices associated with snowballing: a qualitative study. Drug Alcohol Rev. 2010;29(3):256–62.CrossRefPubMed
15.
go back to reference Ahmed T, Long TN, Huong PT, Stewart DE. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis. BMC Public Health. 2015;15(1):1–13.CrossRef Ahmed T, Long TN, Huong PT, Stewart DE. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis. BMC Public Health. 2015;15(1):1–13.CrossRef
16.
go back to reference Roy E, Arruda N, Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst Use Misuse. 2011;46(9):1142–50.CrossRefPubMedPubMedCentral Roy E, Arruda N, Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst Use Misuse. 2011;46(9):1142–50.CrossRefPubMedPubMedCentral
17.
go back to reference Pouget ER, Hagan H, Des Jarlais DC. Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (Abingdon, England). 2012;107(6):1057–65.CrossRef Pouget ER, Hagan H, Des Jarlais DC. Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (Abingdon, England). 2012;107(6):1057–65.CrossRef
18.
go back to reference Jackson LA, Bailey DL, Fraser JR, Johnson JK, Currie A, Babineau DD. Safer and unsafe injection drug use and sex practices among injection drug users in Halifax, Nova Scotia. An exploratory look at community and interpersonal influences. Can J Public Health. 2002;93(3):219–22.PubMed Jackson LA, Bailey DL, Fraser JR, Johnson JK, Currie A, Babineau DD. Safer and unsafe injection drug use and sex practices among injection drug users in Halifax, Nova Scotia. An exploratory look at community and interpersonal influences. Can J Public Health. 2002;93(3):219–22.PubMed
19.
go back to reference De P, Roy É, Boivin JF, Cox J, Morissette C. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepat. 2008;15(4):279–92.CrossRefPubMedPubMedCentral De P, Roy É, Boivin JF, Cox J, Morissette C. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepat. 2008;15(4):279–92.CrossRefPubMedPubMedCentral
20.
go back to reference Abadie R, Welch-Lazoritz M, Gelpi-Acosta C, Reyes JC, Dombrowski K. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Harm Reduct J. 2016;13:10.CrossRefPubMedPubMedCentral Abadie R, Welch-Lazoritz M, Gelpi-Acosta C, Reyes JC, Dombrowski K. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Harm Reduct J. 2016;13:10.CrossRefPubMedPubMedCentral
21.
go back to reference Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: a qualitative study. Soc Sci Med. 2005;61(3):673–84.CrossRefPubMed Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: a qualitative study. Soc Sci Med. 2005;61(3):673–84.CrossRefPubMed
22.
go back to reference Thanh DC, Moland KM, Fylkesnes K. The context of HIV risk behaviours among HIV-positive injection drug users in Viet Nam: Moving toward effective harm reduction. BMC Public Health. 2009;9:98.CrossRefPubMedPubMedCentral Thanh DC, Moland KM, Fylkesnes K. The context of HIV risk behaviours among HIV-positive injection drug users in Viet Nam: Moving toward effective harm reduction. BMC Public Health. 2009;9:98.CrossRefPubMedPubMedCentral
23.
go back to reference Johnson KM, Fibbi M, Langer D, Silva K, Lankenau SE. Prescription drug misuse and risk behaviors among young injection drug users. J Psychoactive Drugs. 2013;45(2):112–21.CrossRefPubMedPubMedCentral Johnson KM, Fibbi M, Langer D, Silva K, Lankenau SE. Prescription drug misuse and risk behaviors among young injection drug users. J Psychoactive Drugs. 2013;45(2):112–21.CrossRefPubMedPubMedCentral
24.
go back to reference Grund JP, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, et al. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med. 1996;42(5):691–703.CrossRefPubMed Grund JP, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, et al. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med. 1996;42(5):691–703.CrossRefPubMed
25.
go back to reference WHO, UNODC, UNAIDS. Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. 2009. WHO, UNODC, UNAIDS. Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. 2009.
26.
go back to reference Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, et al. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013;17(9):2878–92.CrossRefPubMed Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, et al. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013;17(9):2878–92.CrossRefPubMed
27.
go back to reference Kimber J, Palmateer N, Hutchinson J, Hickman M, Goldberg D, Rhodes T. Harm reduction among injecting drug users - evidence of effectiveness. Harm reduction: evidence, impacts and challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2010. p. 115–63. Kimber J, Palmateer N, Hutchinson J, Hickman M, Goldberg D, Rhodes T. Harm reduction among injecting drug users - evidence of effectiveness. Harm reduction: evidence, impacts and challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2010. p. 115–63.
28.
go back to reference Turner KME, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978–88.CrossRefPubMed Turner KME, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978–88.CrossRefPubMed
29.
go back to reference Jones L, Pickering L, Sumnall H, McVeigh J, Bellis M. A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users. Liverpool John Moores University: Centre for Public Health; 2008. Jones L, Pickering L, Sumnall H, McVeigh J, Bellis M. A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users. Liverpool John Moores University: Centre for Public Health; 2008.
30.
go back to reference McGowan C, Harris M, Rhodes T. Hepatitis C avoidance in injection drug users: a typology of possible protective practices. PLoS One. 2013;8(10):e77038.CrossRefPubMedPubMedCentral McGowan C, Harris M, Rhodes T. Hepatitis C avoidance in injection drug users: a typology of possible protective practices. PLoS One. 2013;8(10):e77038.CrossRefPubMedPubMedCentral
Metadata
Title
Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog
Authors
David Otiashvili
Alisher Latypov
Irma Kirtadze
Umedjon Ibragimov
William Zule
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2016
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-016-0065-2

Other articles of this Issue 1/2016

Substance Abuse Treatment, Prevention, and Policy 1/2016 Go to the issue